270 related articles for article (PubMed ID: 28728075)
1. Immunological tolerance as a barrier to protective HIV humoral immunity.
Schroeder KM; Agazio A; Torres RM
Curr Opin Immunol; 2017 Aug; 47():26-34. PubMed ID: 28728075
[TBL] [Abstract][Full Text] [Related]
2. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
Sadanand S; Suscovich TJ; Alter G
Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
[TBL] [Abstract][Full Text] [Related]
3. Host controls of HIV broadly neutralizing antibody development.
Kelsoe G; Haynes BF
Immunol Rev; 2017 Jan; 275(1):79-88. PubMed ID: 28133807
[TBL] [Abstract][Full Text] [Related]
4. Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.
Verkoczy L; Alt FW; Tian M
Immunol Rev; 2017 Jan; 275(1):89-107. PubMed ID: 28133799
[TBL] [Abstract][Full Text] [Related]
5. Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?
Subbaraman H; Schanz M; Trkola A
Retrovirology; 2018 Jul; 15(1):52. PubMed ID: 30055627
[TBL] [Abstract][Full Text] [Related]
6. Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design.
Finney J; Kelsoe G
Retrovirology; 2018 Jul; 15(1):53. PubMed ID: 30055635
[TBL] [Abstract][Full Text] [Related]
7. 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.
Kobie JJ; Alcena DC; Zheng B; Bryk P; Mattiacio JL; Brewer M; Labranche C; Young FM; Dewhurst S; Montefiori DC; Rosenberg AF; Feng C; Jin X; Keefer MC; Sanz I
PLoS One; 2012; 7(4):e35356. PubMed ID: 22530008
[TBL] [Abstract][Full Text] [Related]
8. Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.
Ahmed Y; Tian M; Gao Y
AIDS Res Ther; 2017 Sep; 14(1):50. PubMed ID: 28893278
[TBL] [Abstract][Full Text] [Related]
9. Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models.
Tian M; McGovern K; Cheng HL; Waddicor P; Rieble L; Dao M; Chen Y; Kimble MT; Cantor E; Manfredonia N; Judson R; Chapdelaine-Williams A; Cain DW; Haynes BF; Alt FW
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7929-7940. PubMed ID: 32209668
[TBL] [Abstract][Full Text] [Related]
10. Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10.
Doyle-Cooper C; Hudson KE; Cooper AB; Ota T; Skog P; Dawson PE; Zwick MB; Schief WR; Burton DR; Nemazee D
J Immunol; 2013 Sep; 191(6):3186-3191. PubMed ID: 23940276
[TBL] [Abstract][Full Text] [Related]
11. Antibody B cell responses in HIV-1 infection.
Mouquet H
Trends Immunol; 2014 Nov; 35(11):549-61. PubMed ID: 25240985
[TBL] [Abstract][Full Text] [Related]
12. Immunological mechanisms of inducing HIV immunity in infants.
Fouda GG; De Paris K; Levy O; Marchant A; Gray G; Permar S; Marovich M; Singh A
Vaccine; 2020 Jan; 38(3):411-415. PubMed ID: 31761501
[TBL] [Abstract][Full Text] [Related]
13. Correlations between HIV-1 clades and HIV-1 antibody neutralization sensitivity: significant for vaccine development?
van Gils MJ; Schuitemaker H
Curr HIV Res; 2010 Dec; 8(8):579-86. PubMed ID: 21054254
[TBL] [Abstract][Full Text] [Related]
14. On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?
Parsons MS; Muller S; Kohler H; Grant MD; Bernard NF
Hum Vaccin Immunother; 2013 Jul; 9(7):1532-8. PubMed ID: 23571168
[TBL] [Abstract][Full Text] [Related]
15. Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.
Havenar-Daughton C; Lee JH; Crotty S
Immunol Rev; 2017 Jan; 275(1):49-61. PubMed ID: 28133798
[TBL] [Abstract][Full Text] [Related]
16. Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages.
Zhang R; Verkoczy L; Wiehe K; Munir Alam S; Nicely NI; Santra S; Bradley T; Pemble CW; Zhang J; Gao F; Montefiori DC; Bouton-Verville H; Kelsoe G; Larimore K; Greenberg PD; Parks R; Foulger A; Peel JN; Luo K; Lu X; Trama AM; Vandergrift N; Tomaras GD; Kepler TB; Moody MA; Liao HX; Haynes BF
Sci Transl Med; 2016 Apr; 8(336):336ra62. PubMed ID: 27122615
[TBL] [Abstract][Full Text] [Related]
17. Role of humoral immunity in host defense against HIV.
Baum LL
Curr HIV/AIDS Rep; 2010 Feb; 7(1):11-8. PubMed ID: 20425053
[TBL] [Abstract][Full Text] [Related]
18. Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies.
Geiß Y; Dietrich U
AIDS Rev; 2015; 17(2):107-13. PubMed ID: 26035168
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.
Kwong PD; Mascola JR
Immunity; 2018 May; 48(5):855-871. PubMed ID: 29768174
[TBL] [Abstract][Full Text] [Related]
20. Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination.
Martinez DR; Permar SR; Fouda GG
Clin Vaccine Immunol; 2016 Feb; 23(2):84-94. PubMed ID: 26656117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
